| Product Code: ETC6664029 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Pharmacogenetic Testing Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Canada Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Canada Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Canada Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Canada Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Canada Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Canada Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Canada Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Canada Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growing awareness about pharmacogenetic testing |
4.2.3 Supportive government initiatives and policies |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies |
4.3.3 Lack of skilled healthcare professionals |
5 Canada Pharmacogenetic Testing Market Trends |
6 Canada Pharmacogenetic Testing Market, By Types |
6.1 Canada Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Canada Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Canada Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Canada Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Canada Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Canada Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Canada Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Canada Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Canada Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Canada Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Canada Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Canada Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Canada Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Canada Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Canada Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Canada Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Canada Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Canada Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Canada Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Canada Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Canada Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Canada Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Canada Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Canada Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Canada Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Canada Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Canada Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Canada Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Canada Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Canada Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Canada Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Canada Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Canada Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Canada Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Canada Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Canada Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Canada Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Canada Pharmacogenetic Testing Market Export to Major Countries |
7.2 Canada Pharmacogenetic Testing Market Imports from Major Countries |
8 Canada Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of research studies and publications on pharmacogenetic testing |
8.3 Rate of integration of pharmacogenetic testing into clinical practice |
9 Canada Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Canada Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Canada Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Canada Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Canada Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Canada Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Canada Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Canada Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Canada Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Canada Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here